Entero Healthcare Solutions Ltd. Fundamental & Technical Research, Share Price Today

NSE : ENTERO
NIFTY : Nifty Microcap 250

About Company

Entero Healthcare Solutions Limited is one of India's largest and fastest growing healthcare products distribution platforms. The company offers both demand generation and demand fulfilment solutions to healthcare product manufacturers. It offers demand generation solutions to healthcare product manufacturers by promoting and creating awareness of their product brands to healthcare professionals, doctors and channels such as pharmacies, hospitals (both private and government), clinics and customers through e-commerce marketplaces. Further, it provides end-to-end healthcare products distribution solutions including imports, central warehousing, redistribution, last mile delivery and connection with the pharmacies, hospitals and clinics.<br>

Market Cap. ₹4,989 Cr.

52 Week - High/Low ₹1,584/991

P/E Ratio 54.63

P/B Ratio 3.07

Enterprise Value ₹4,197 Cr.

ROE % 4.98

RSI Value 95.35

EMA 50 1156.75

EMA 200 1155.21

Net Profit 38 Cr.

Net Profit 3year growth -311.77 Cr.

Net Profit 3 year (back) -18 Cr.

Debt to Equity 0.0 %

EPS Growth TTM 13893.33 %

Current Ratio 12.99 %

100 Day SMA 1,329 Rs.

200 Day SMA 1,306 Rs.

21 Day SMA 1,176 Rs.

50 Day SMA 1,265 Rs.

Book Value 374 Rs.

EV/EBITDA Ratio 41

QoQ EPS Growth -30 %

QoQ Operating Profit Growth 73 %

QoQ Sales Growth -10 %

Sales Latest Quarter 101 Cr.

YoY Sales Growth 32 %

Market Cap. ₹4,989 Cr.

52 Week - High/Low ₹1,584/991

P/E Ratio 53.01

P/B Ratio 3.05

Enterprise Value ₹4,178 Cr.

ROE % 5.08

RSI Value 95.35

EMA 50 1156.75

EMA 200 1155.21

Net Profit 39 Cr.

Net Profit 3year growth 35.45 Cr.

Net Profit 3 year (back) -16 Cr.

Debt to Equity 0.17 %

EPS Growth TTM 222.35 %

Current Ratio 3.34 %

100 Day SMA 1,329 Rs.

200 Day SMA 1,306 Rs.

21 Day SMA 1,176 Rs.

50 Day SMA 1,265 Rs.

Book Value 376 Rs.

EV/EBITDA Ratio 22

QoQ EPS Growth 8 %

QoQ Operating Profit Growth 18 %

QoQ Sales Growth 4 %

Sales Latest Quarter 1,359 Cr.

YoY Sales Growth 37 %

Add Parameters

Valuation

Peer Comparison

Industry - Trading

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages